205 related articles for article (PubMed ID: 7732205)
1. [Study of anti-loxosceles serum action on hemolytic and ulcero-necrotic cutaneous effects of Loxosceles laeta venom].
Bravo M; Oviedo I; Farías P; Schenone H
Rev Med Chil; 1994 Jun; 122(6):625-9. PubMed ID: 7732205
[TBL] [Abstract][Full Text] [Related]
2. [Hemolysis induced by Loxosceles laeta venom. In vitro experience].
Bravo M; Puratic O; Behn C; Fardella C; Contreras A
Rev Med Chil; 1993 Jan; 121(1):16-20. PubMed ID: 8235159
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous loxoscelism caused by Loxosceles similis venom and neutralization capacity of its specific antivenom.
Chatzaki M; Horta CC; Almeida MO; Pereira NB; Mendes TM; Dias-Lopes C; Guimarães G; Moro L; Chávez-Olórtegui C; Horta MC; Kalapothakis E
Toxicon; 2012 Jul; 60(1):21-30. PubMed ID: 22465492
[TBL] [Abstract][Full Text] [Related]
4. Analysis of therapeutic benefits of antivenin at different time intervals after experimental envenomation in rabbits by venom of the brown spider (Loxosceles intermedia).
Pauli I; Minozzo JC; da Silva PH; Chaim OM; Veiga SS
Toxicon; 2009 May; 53(6):660-71. PubMed ID: 19673081
[TBL] [Abstract][Full Text] [Related]
5. Incorporation of a 35-kilodalton purified protein from Loxosceles intermedia spider venom transforms human erythrocytes into activators of autologous complement alternative pathway.
Tambourgi DV; Magnoli FC; Von Eickstedt VR; Benedetti ZC; Petricevich VL; da Silva WD
J Immunol; 1995 Nov; 155(9):4459-66. PubMed ID: 7594608
[TBL] [Abstract][Full Text] [Related]
6. Variations in Loxosceles spider venom composition and toxicity contribute to the severity of envenomation.
de Oliveira KC; Gonçalves de Andrade RM; Piazza RM; Ferreira JM; van den Berg CW; Tambourgi DV
Toxicon; 2005 Mar; 45(4):421-9. PubMed ID: 15733563
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the venom from the Brazilian Brown Spider Loxosceles similis Moenkhaus, 1898 (Araneae, Sicariidae).
Silvestre FG; de Castro CS; de Moura JF; Giusta MS; De Maria M; Alvares ES; Lobato FC; Assis RA; Gonçalves LA; Gubert IC; Chávez-Olórtegui C; Kalapothakis E
Toxicon; 2005 Dec; 46(8):927-36. PubMed ID: 16289643
[TBL] [Abstract][Full Text] [Related]
8. Enzymatic characterization, antigenic cross-reactivity and neutralization of dermonecrotic activity of five Loxosceles spider venoms of medical importance in the Americas.
Barbaro KC; Knysak I; Martins R; Hogan C; Winkel K
Toxicon; 2005 Mar; 45(4):489-99. PubMed ID: 15733571
[TBL] [Abstract][Full Text] [Related]
9. Biochemical and immunological characteristics of Peruvian Loxosceles laeta spider venom: neutralization of its toxic effects by anti-loxoscelic antivenoms.
Guimarães G; Dias-Lopes C; Duarte CG; Felicori L; Machado de Avila RA; Figueiredo LF; de Moura J; Faleiro BT; Barro J; Flores K; Silva W; Tintaya B; Yarleque A; Bonilla C; Kalapothakis E; Salas CE; Chávez-Olortegui C
Toxicon; 2013 Aug; 70():90-7. PubMed ID: 23648420
[TBL] [Abstract][Full Text] [Related]
10. Survey for potentially necrotizing spider venoms, with special emphasis on Cheiracanthium mildei.
Foradori MJ; Smith SC; Smith E; Wells RE
Comp Biochem Physiol C Toxicol Pharmacol; 2005 May; 141(1):32-9. PubMed ID: 15979415
[TBL] [Abstract][Full Text] [Related]
11. Toxicity of two North American Loxosceles (brown recluse spiders) venoms and their neutralization by antivenoms.
de Roodt AR; Estevez-Ramírez J; Litwin S; Magaña P; Olvera A; Alagón A
Clin Toxicol (Phila); 2007 Sep; 45(6):678-87. PubMed ID: 17849243
[TBL] [Abstract][Full Text] [Related]
12. Tetracycline and penicillin resistant Clostridium perfringens isolated from the fangs and venom glands of Loxosceles laeta: its implications in loxoscelism treatment.
Catalán A; Espoz MC; Cortés W; Sagua H; González J; Araya JE
Toxicon; 2010 Nov; 56(6):890-6. PubMed ID: 20600224
[TBL] [Abstract][Full Text] [Related]
13. A reduced immunization scheme to obtain an experimental anti-Loxosceles laeta ("violinist spider") venom.
de Roodt AR; Litwin S; Dokmetjian JC; Vidal JC
J Nat Toxins; 2002 Aug; 11(3):193-203. PubMed ID: 12182539
[TBL] [Abstract][Full Text] [Related]
14. Identification and neutralization of biological activities in the venoms of Loxosceles spiders.
Barbaro KC; Ferreira ML; Cardoso DF; Eickstedt VR; Mota I
Braz J Med Biol Res; 1996 Nov; 29(11):1491-7. PubMed ID: 9196551
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of complement by Loxosceles reclusa spider venom.
Gebel HM; Finke JH; Elgert KD; Cambell BJ; Barrett JT
Am J Trop Med Hyg; 1979 Jul; 28(4):756-62. PubMed ID: 464196
[TBL] [Abstract][Full Text] [Related]
16. Development of an acute cutaneous swine model for Loxosceles envenomation.
Hobbs GD; Yealy DM
Vet Hum Toxicol; 1994 Aug; 36(4):298-300. PubMed ID: 7975131
[TBL] [Abstract][Full Text] [Related]
17. Biological and structural comparison of recombinant phospholipase D toxins from Loxosceles intermedia (brown spider) venom.
Ribeiro RO; Chaim OM; da Silveira RB; Gremski LH; Sade YB; Paludo KS; Senff-Ribeiro A; de Moura J; Chávez-Olórtegui C; Gremski W; Nader HB; Veiga SS
Toxicon; 2007 Dec; 50(8):1162-74. PubMed ID: 17900646
[TBL] [Abstract][Full Text] [Related]
18. Synthetic peptides for in vitro evaluation of the neutralizing potency of Loxosceles antivenoms.
Ramada JS; Becker-Finco A; Minozzo JC; Felicori LF; Machado de Avila RA; Molina F; Nguyen C; de Moura J; Chávez-Olórtegui C; Alvarenga LM
Toxicon; 2013 Oct; 73():47-55. PubMed ID: 23856101
[TBL] [Abstract][Full Text] [Related]
19. Two new phospholipase D isoforms of Loxosceles laeta: cloning, heterologous expression, functional characterization, and potential biotechnological application.
Catalán A; Cortes W; Sagua H; González J; Araya JE
J Biochem Mol Toxicol; 2011; 25(6):393-403. PubMed ID: 21692149
[TBL] [Abstract][Full Text] [Related]
20. Functional alterations of rabbit erythrocytes induced by Loxosceles gaucho venom.
Barretto OC; Soeiro Prestes K; Figueiredo Fonseca LK; Achucarro Silveira PA
Hum Exp Toxicol; 2007 Oct; 26(10):817-21. PubMed ID: 18025054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
